A Patch Model for Pandemic Influenza Simulation in Korea

2010 Sixth IEEE International Conference on e-Science Workshops ◽

10.1109/esciencew.2010.20 ◽

2010 ◽

Author(s):

Hoon Choi ◽

Dong-In Park

Keyword(s):

Pandemic Influenza ◽

Patch Model

U.S. Urged to Revise Its Pandemic Influenza Plan

Internal Medicine News ◽

10.1016/s1097-8690(06)74304-9 ◽

2006 ◽

Vol 39 (19) ◽

pp. 47

Author(s):

KATE JOHNSON

Keyword(s):

Pandemic Influenza

VA Seasonal and Pandemic Influenza Programs: Public Health, Performance and Preparedness

PsycEXTRA Dataset ◽

10.1037/e510722006-001 ◽

2006 ◽

Author(s):

Lawrence R. Deyton

Keyword(s):

Public Health ◽

Pandemic Influenza ◽

Health Performance ◽

Public Health Performance

A novel methodological approach to systematically analyse pandemic influenza response programs within health systems

Das Gesundheitswesen ◽

10.1055/s-0030-1266539 ◽

2010 ◽

Vol 72 (08/09) ◽

Author(s):

A Ahmad ◽

R Krumkamp ◽

S Mounier-Jack ◽

R Reintjes ◽

R Coker

Keyword(s):

Health Systems ◽

Pandemic Influenza ◽

Methodological Approach

Effectively Assessing Exposire to Pandemic Influenza

The Synergist ◽

10.3320/1.2759324 ◽

2006 ◽

Vol 17 (9) ◽

pp. 36 ◽

Cited By ~ 1

Author(s):

Joselito S. Ignacio

Keyword(s):

Pandemic Influenza

Neurologic Disorders Among Pediatric Deaths Associated With the 2009 Pandemic Influenza

PEDIATRICS ◽

10.1542/peds.2011-3343d ◽

2012 ◽

Vol 130 (3) ◽

pp. X2-X2

Keyword(s):

Pandemic Influenza ◽

Neurologic Disorders

Comparative analysis of clinic-epidemiological profile of 2009 and 2016 pandemic influenza А/(H1N1) in hospitalized children of Zaporozhye region

SOVREMENNAYA PEDIATRIYA ◽

10.15574/sp.2017.82.47 ◽

2017 ◽

Vol 82 (2) ◽

pp. 47-51

Author(s):

O.V. Konakova ◽

◽

O.V. Ysachova ◽

E.A. Silina ◽

T.M. Pakholchuk ◽

...

Keyword(s):

Comparative Analysis ◽

Pandemic Influenza ◽

Hospitalized Children ◽

Epidemiological Profile

Human medicines European public assessment report (EPAR): Foclivia, pandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted), Influenza, Human,Immunization,Disease Outbreaks, Date of authorisation: 18/10/2009, Revision: 8, Status: Authorised

Case Medical Research ◽

10.31525/cmr-913586 ◽

2019 ◽

Author(s):

Keyword(s):

Influenza Vaccine ◽

Surface Antigen ◽

Pandemic Influenza ◽

Disease Outbreaks ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Human medicines European public assessment report (EPAR): Adjupanrix (previously Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals), pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted), Influenza, Human,Immunization,Disease Outbreaks, Date of authorisation: 10/10/2009, Revision: 9, Status: Authorised

Case Medical Research ◽

10.31525/cmr-5871ee ◽

2018 ◽

Author(s):

Keyword(s):

Influenza Vaccine ◽

Pandemic Influenza ◽

Disease Outbreaks ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Faculty Opinions recommendation of Bacterial pneumonia and pandemic influenza planning.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1162201.622673 ◽

2009 ◽

Author(s):

Mathias Pletz

Keyword(s):

Pandemic Influenza ◽

Bacterial Pneumonia

Faculty Opinions recommendation of Risk of fetal death after pandemic influenza virus infection or vaccination.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717971424.793470071 ◽

2013 ◽

Author(s):

Laxmi Baxi ◽

Tessie Tharakan

Keyword(s):

Influenza Virus ◽

Virus Infection ◽

Pandemic Influenza ◽

Fetal Death ◽

Influenza Virus Infection